New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
Trending
- Brown (2026) Review: Karisma Kapoor Delivers a Career-Defining Performance in This Hauntingly Beautiful Zee5 Crime Drama
- Gullak Season 5 Review: The Mishras Are Back and More Heartwarming Than Ever
- Mango Pachcha Review (2026): A Gritty Crime Drama That Hits Close to Home
- Peddi (2026) Movie Review: Ram Charan’s Career-Best Performance Powers a Stirring Tale of Grit, Identity and Belonging
- Parimala And Co (2026) Review: Pandiraj’s Warm Whodunit Is a Comfortable, Crowd-Pleasing Ride
- Bandar (2026) Review: Bobby Deol’s Most Daring Performance Yet in Anurag Kashyap’s Brutal Prison Drama
- Hai Jawani Toh Ishq Hona Hai Review: Varun Dhawan’s Most Entertaining Comedy in Years
- Maa Behen Review (2026): Madhuri Dixit, Triptii Dimri Deliver a Wickedly Funny Crime-Comedy That Refuses to Apologise